Stock Rich List
#2971 on the rich list of 14,644 insiders

Bihua Chen

Director at Erasca; 10% owner at MoonLake Immunotherapeutics; Chairperson and CEO at Helix Acquisition Corp. III. Based in Boston, Massachusetts.

$40.6M
in disclosed stock, +$883K (+2.22%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
2971st of 14,644
Companies held
1
Largest holding
MLTX, 100.0% of total
Latest SEC filing
Jul 1, 2026
Listed but not counted
$315M

What the $40.6M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
Through Helix Holdings LLC3,677,100$11.03$40.6M100.0%Form 4, Jun 30, 2023

Share counts are the amounts Bihua Chen reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Bihua Chen's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Erasca ERAS
Common Stock
Through Cormorant Global Healthcare Master Fund, LP
Held by a company or fund the insider manages
10,505,554$14.22$149M—Form 4, Jun 22, 2022
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
Through Cormorant Asset Management, LP
Held by a company or fund the insider manages
4,927,100$11.03$54.3M—Form 4, Jun 30, 2023
Helix Acquisition Corp. III HLXC
Class B Ordinary Shares
Indirectly (see filing footnote)
Held by a company or fund the insider manages
4,252,500$10.30$43.8M—Form 4/A, Jan 22, 2026
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Master Fund
Held by a company or fund the insider manages
6,083,221$1.86$11.3M—Form 4, Jul 1, 2026
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Master Fund
Held by a company or fund the insider manages
5,952,356$1.86$11.1M—Form 4, Aug 11, 2025
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Fund V
Held by a company or fund the insider manages
5,010,332$1.86$9.3M—Form 4, Jul 1, 2026
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Fund III
Held by a company or fund the insider manages
4,879,995$1.86$9.1M—Form 4, Jul 1, 2026
Helix Acquisition Corp. III HLXC
Class A Ordinary Shares
Through Cormorant Global Healthcare Master Fund, LP
Held by a company or fund the insider manages
800,000$10.30$8.2M—Form 4/A, Jan 26, 2026
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Fund V
Held by a company or fund the insider manages
3,305,470$1.86$6.1M—Form 4, Aug 11, 2025
Helix Acquisition Corp. III HLXC
Class A Ordinary Shares
Indirectly (see filing footnote)
Held by a company or fund the insider manages
497,500$10.30$5.1M—Form 4/A, Jan 26, 2026
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Fund III
Held by a company or fund the insider manages
2,187,536$1.86$4.1M—Form 4, Aug 11, 2025
BridgeBio Oncology Therapeutics BBOT
Common Stock
Via Fund IV
Held by a company or fund the insider manages
1,905,046$1.86$3.5M—Form 4, Jul 1, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jan 26, 2026BoughtHLXC800,000$10.00$8.0MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2968H. Lynn Moore Jr.
President and CEO, Tyler Technologies. Plano, TX
$40.6M−$623K (−1.51%)
2969Richard G. Thornberry
Chief Executive Officer, Radian Group. Wayne, PA
$40.6M−$67K (−0.16%)
2970Suzanne Helen
Insider, Mohawk Industries. Dalton, GA
$40.6M−$1.6M (−3.77%)
2971Bihua Chen
Director, Erasca. Boston, MA
$40.6M+$883K (+2.22%)
2972David Joseph Meyer
Chairman, Titan Machinery. West Fargo, ND
$40.6M−$1.1M (−2.53%)
2973Christopher P. Marr
CEO, CubeSmart. Boston, MA
$40.5M−$347K (−0.85%)
2974John Caplan
Chief Executive Officer, Payoneer Global. New York, NY
$40.5M−$57K (−0.14%)

Other Erasca insiders

All ERAS insiders

Questions

How much stock does Bihua Chen own?

Bihua Chen holds $40,558,413 in listed stock based on SEC filings and current prices, mostly MoonLake Immunotherapeutics (MLTX). That ranks 2971st on the Stock Rich List.

Is this Bihua Chen's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Bihua Chen last buy or sell stock?

The most recent open-market trade on file is a purchase of 800,000 HLXC shares on Jan 26, 2026 at $10.00.